Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable | Zendy

Zachary S. Zumsteg | Zendy; Daniel E. Spratt | Zendy; Timothy J. Daskivich | Zendy; Mourad Tighiouart | Zendy; Michael Luu | Zendy; Joseph P. Rodgers | Zendy; Howard M. Sandler | Zendy

Open Access

Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable

Author(s) -

Zachary S. Zumsteg,

Daniel E. Spratt,

Timothy J. Daskivich,

Mourad Tighiouart,

Michael Luu,

Joseph P. Rodgers,

Howard M. Sandler

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.15083

Subject(s) - androgen deprivation therapy , prostate cancer , medicine , radiation therapy , oncology , randomized controlled trial , androgen , prostate , cancer , hormone

This secondary analysis of a randomized clinical trial examines the effect of androgen deprivation therapy (ADT) during radiotherapy in patients who were classified as having either favorable intermediate-risk or unfavorable intermediate-risk prostate cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research